(Total Views: 538)
Posted On: 08/26/2024 12:13:09 AM
Post# of 154713
12 yrs knocks off 6 yrs of LL's patent protection, as of today. That's significant.
" we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”
Why would a new formula, get less than 20 yr?
" we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”
Why would a new formula, get less than 20 yr?
(1)
(0)
